Compare SYNX & XXII Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | SYNX | XXII |
|---|---|---|
| Founded | 2005 | 1998 |
| Country | Israel | United States |
| Employees | N/A | N/A |
| Industry | | Medicinal Chemicals and Botanical Products |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.5M | 6.1M |
| IPO Year | 2024 | N/A |
| Metric | SYNX | XXII |
|---|---|---|
| Price | $1.17 | $0.90 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 209.8K | 180.9K |
| Earning Date | 02-23-2026 | 11-04-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $6,003,000.00 | ★ $20,346,000.00 |
| Revenue This Year | $32.35 | N/A |
| Revenue Next Year | N/A | $79.56 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 16.98 |
| 52 Week Low | $0.73 | $0.75 |
| 52 Week High | $4.69 | $287.27 |
| Indicator | SYNX | XXII |
|---|---|---|
| Relative Strength Index (RSI) | 56.35 | 46.08 |
| Support Level | $1.10 | $0.86 |
| Resistance Level | $1.29 | $0.99 |
| Average True Range (ATR) | 0.11 | 0.07 |
| MACD | 0.05 | 0.01 |
| Stochastic Oscillator | 83.98 | 62.60 |
Silynxcom Ltd is engaged in developing, manufacturing, marketing, and selling ruggedized Personal Headset Devices as well as other communications accessories, all of which have been battlefield-tested and combat proved. It specializes in developing the In-Ear Headset device, a subsegment of the Personal Headset Device market. The In-Ear Headset device is used in both training and operations by the military, law enforcement, and disaster recovery industry professionals. It also develops, markets, and sell push-to-talk devices, communication controllers, and communication device cables and connectors.
22nd Century Group Inc is a United States-based biotechnology company focused on utilizing alkaloid plant technologies to improve health and wellness with reduced nicotine tobacco, and hemp/cannabis. It has one operating segment; The tobacco segment is engaged in commercializing its proprietary VLNC tobacco plants and cigarette products, which contain nicotine than conventional tobacco and cigarettes, and research cigarettes sold under the brand name SPECTRUM. It derives a majority of its revenue from the tobacco segment.